In the present study, we observed that IL-23 blockade improves glucose tolerance, preserves insulin sensitivity, and supports liver function in Atg5 CD11c deficient mice, thus demonstrating that autophagy deficiency upregulates IL-23 secretion in CD11c+ cells, contributing to NAFLD development. This evidence concerns the gene ATG5 and metabolic dysfunction-associated steatotic liver disease.